Free Trial

Fennec Pharmaceuticals (FRX) Earnings Date, Estimates & Call Transcripts

Fennec Pharmaceuticals logo
C$5.65 -0.45 (-7.38%)
(As of 11/15/2024 ET)

Fennec Pharmaceuticals Latest Earnings Summary

Upcoming Q3
Earnings Date
Mar. 20Estimated
Actual EPS
(Aug. 13)
-C$0.27 Missed By -C$0.35
Consensus EPS
(Aug. 13)
C$0.08

Fennec Pharmaceuticals issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -C$0.27, which missed the consensus estimate of C$0.08 by C$0.35. Quarterly revenue was reported to be C$9.94 million, below analyst estimates of C$18.67 million. With a trailing EPS of C$0.10 and a P/E Ratio of 56.50,

FRX Upcoming Earnings

Fennec Pharmaceuticals' next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules.

Get Fennec Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

FRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fennec Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-C$0.07C$0.03-C$0.02
Q2 20243-C$0.24C$0.58C$0.08
Q3 20243-C$0.22C$0.33C$0.05
Q4 20243-C$0.18C$0.58C$0.15
FY 202411-C$0.71C$1.52C$0.25
Q1 20252C$0.11C$0.19C$0.15
Q2 20252C$0.12C$0.26C$0.19
Q3 20252C$0.16C$0.34C$0.25
Q4 20252C$0.18C$0.47C$0.33
FY 20258C$0.57C$1.26C$0.92

Fennec Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/20/2025
(Estimated)
------- 
8/13/2024Q2 2024C$0.08C-$0.27 -C$0.35C-$0.27C$18.67MC$9.94M
5/14/2024Q1 2024C$0.67C$0.56 -C$0.11C$0.56C$14.19MC$34.21M
3/21/2024Q4 2023C$0.02C-$0.14 -C$0.16C-$0.14C$12.88MC$13.25M
11/6/2023Q3 2023C-$0.15C-$0.09+C$0.06C-$0.09C$6.94MC$8.74M
8/3/2023Q2 2023C-$0.24C-$0.28 -C$0.04C-$0.28C$5.41MC$4.47M
5/11/2023Q1 2023C-$0.29C-$0.31 -C$0.02C-$0.31C$2.53MC$2.27M
3/30/2023Q4 2022C-$0.33C-$0.35 -C$0.02C-$0.35--


This page (TSE:FRX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners